CLP-1001: Phase IIb started

Sorbent began the double-blind, placebo-controlled, U.S. Phase IIb STEPWISE trial to evaluate twice daily 15 g CLP-1001 in about 250 patients with signs and symptoms of fluid overload following a rece...